Compare GPK & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPK | RXRX |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.2B |
| IPO Year | 2007 | 2021 |
| Metric | GPK | RXRX |
|---|---|---|
| Price | $8.72 | $3.80 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $10.95 | $7.32 |
| AVG Volume (30 Days) | 6.7M | ★ 25.4M |
| Earning Date | 11-03-2026 | 11-09-2026 |
| Dividend Yield | ★ 5.02% | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,617,000,000.00 | $74,681,000.00 |
| Revenue This Year | $0.18 | N/A |
| Revenue Next Year | $1.95 | $26.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $8.15 | $2.77 |
| 52 Week High | $17.39 | $6.23 |
| Indicator | GPK | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.58 | 50.23 |
| Support Level | N/A | $2.90 |
| Resistance Level | $10.04 | $4.09 |
| Average True Range (ATR) | 0.32 | 0.37 |
| MACD | 0.10 | -0.06 |
| Stochastic Oscillator | 59.44 | 31.47 |
Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Americas Paperboard Packaging, and International Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company operates in Americas, Europe and Asia Pacific regions.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.